Company profile: Avrobio
1.1 - Company Overview
Company description
- Provider of clinical-stage cell and gene therapies under development targeting cancer and rare disease.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Avrobio
Nextcode
HQ: United States
Website
- Description: Provider of sequence-based clinical diagnostics and genome interpretation solutions that address big data challenges, leveraging technology developed over more than 16 years at deCODE genetics to enable the widespread incorporation of genome sequence data into patient diagnosis and care.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nextcode company profile →
Tute Genomics
HQ: United States
Website
- Description: Provider of a cloud-based clinical genome interpretation platform that rapidly analyzes and annotates personal genomes, enabling researchers and clinicians to utilize human genome data for scientific discovery and individualized treatment, incorporating proprietary machine-learning algorithms.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tute Genomics company profile →
QuantuMDx
HQ: United Kingdom
Website
- Description: Provider of handheld and portable low-cost diagnostic and genomic sequencing platforms, including the Q-POC rapid multiplex PCR point-of-care system; assays for SARS-CoV-2, Flu A/B, RSV; a research-use TB host immune response assay; a saliva-based SARS-CoV-2 RT-PCR test; CAPTURE-XT lab-on-chip pathogen concentration; and microarray technologies for high-throughput genetic marker screening.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full QuantuMDx company profile →
Qiagen
HQ: The Netherlands
Website
- Description: Provider of technologies and products for preanalytical sample preparation and linked molecular assay solutions. Supplies diagnostic kits, tests, and assays for human and veterinary molecular diagnostics, with sample and assay consumables offered in kit form. Portfolio includes automated nucleic acid purification systems, sample disruption tools, real-time and digital PCR platforms, and automated PCR setup.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Qiagen company profile →
Renova Therapeutics
HQ: United States
Website
- Description: Provider of gene therapies for chronic diseases, focusing on cardiovascular and metabolic indications. Offerings include RT-100, a single-dose therapy to improve heart function in congestive heart failure; RT-200, a single intravenous therapy to normalize blood glucose in Type 2 Diabetes Mellitus; and paracrine gene therapy enabling systemic delivery of therapeutic genes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Renova Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Avrobio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Avrobio
2.2 - Growth funds investing in similar companies to Avrobio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Avrobio
4.2 - Public trading comparable groups for Avrobio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →